Rejecting False Claims from Markov Simulations in Alzheimer's Disease
There is no abstract as this is a letter
Saved in:
Main Author: | Paul Langley (Author) |
---|---|
Format: | Book |
Published: |
University of Minnesota Libraries Publishing,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-Effectiveness of a Hypothetical Gene Therapy for Alzheimer's Disease: A Markov Simulation Analysis
by: Thuy Chinh Kieu, et al.
Published: (2023) -
Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation
by: Budd D, et al.
Published: (2011) -
Imaginary Worlds: The Status of Simulation Modeling in Claims for Cost-Effectiveness In Diabetes Mellitus
by: Paul C Langley, et al.
Published: (2016) -
Value Assessment in Cystic Fibrosis: ICER's Rejection of the Axioms of Fundamental Measurement
by: Paul Langley
Published: (2020) -
HAS Should Not Be NICE: Rejecting Imaginary Worlds in the French Technology Assessment Guidelines
by: Paul C Langley
Published: (2017)